Phase III Study of Three Intensive Post-Remission Therapies in Adult Acute Non-Lymphocytic Leukemia: Comparison of Autologous Bone Marrow Transplantation, Intensive Chemotherapy and Allogeneic Bone Marrow Transplantation
Research committees
Publication Information Expand/Collapse
2015
PMid: PMID25113226 | PMC number: PMC4318722
2014
Unsuccessful cytogenetic analysis is a poor prognostic feature in acute myeloid leukemia
PMid: PMID24383844 | PMC number: PMC4117470
2013
PMid: PMID23325837 | PMC number: PMC3612855
2012
Impact of residual normal metaphases in core binding factor acute myeloid leukemia
PMid: PMID21928314 | PMC number: PMC3490403
2011
Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype [PMID21330329; PMC3069244]
Cytarabine dose for acute myeloid leukemia. (Letter to the Editor) [PMID21631340]
Prediction of early death following induction therapy for newly diagnosed acute leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
PMid: PMID21969499 | PMC number: PMC3221524
2010
PMid: PMID20562328 | PMC number: PMC3709629
Influence of residual normal metaphases in patients with monosomal karyotype
2006
Age and acute myeloid leukemia
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
Letter to the editor: A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies
2001
The significance of trisomy 8 in myeloid leukemia: a Southwest Oncology Group (SWOG) study.
2000
Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study.
1999
Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1).
1998
Karyotypic analysis predicts outcome of pre-and post- remission therapy in adult acute myeloid leukemia (AML): A SWOG/ECOG intergroup study.
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
Cell cycle arrest and therapeutic sensitivity in de novo AML.
1997
Comparison of autologous bone marrow transplant (AUTOBMT) with high-dose cytarabine (HDAC) in adult acute myeloid leukemia (AML) in first remission (CR1): an ECOG intergroup study.
Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
1996
Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
Spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
Characterization and rapid diagnostic utility of a novel antibody detecting the CBFB/SMMHC fusion protein of inversion(16)/t(16;16) associated acute myeloid leukemia.
The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
1995
Trisomy 11: an association with stem/progenitor cell immunophenotype.
1993
An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22).
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.